Ask any dentist who's worked on a redheaded patient long enough, and you'll probably hear some version of the same story: the local anesthetic that works fine on most people doesn't quite seem to numb them the same way. That anecdotal pattern turns out to have real genetics behind it, tracing back to a single gene most people associate purely with hair color.
One Gene, Two Very Different Jobs
MC1R (melanocortin 1 receptor) sits on the surface of melanocytes, the cells responsible for producing pigment. In most people, it triggers the production of eumelanin — the darker pigment that protects skin from UV damage. In people with certain MC1R variants, the receptor doesn't function properly, and melanocytes default to producing pheomelanin instead — the red-toned pigment responsible for red hair, and a pigment that offers considerably less protection from ultraviolet radiation.
Because red hair is a recessive trait, it takes one non-working copy of MC1R from each parent to actually produce red hair — which is part of why it's rare even though the variant itself isn't. But MC1R doesn't stop at pigmentation. Researchers have found that its influence extends into a part of biology that seems, on the surface, completely unrelated: how the body processes pain and responds to anesthesia.
What the Research Actually Shows
To be fair to the science here: this is one of the more debated areas of pharmacogenomic research. Not every study agrees, and a 2020 paper argued that the specific MC1R variants linked to altered pain sensitivity may actually be distinct from the variants that cause red hair itself, meaning the relationship might be more complicated — or more coincidental — than the popular narrative suggests. What's not in dispute is the anecdotal consistency reported by anesthesiologists and dentists across decades of clinical practice, which is exactly the kind of pattern pharmacogenomic research exists to explain.
The Skin Cancer Risk That's Much Better Established
Separate from the anesthesia question, MC1R's role in melanoma risk is on much firmer scientific ground. Because pheomelanin offers far less UV protection than eumelanin, and because MC1R itself plays a role in DNA-damage repair after UV exposure, carriers of red-hair-associated MC1R variants face substantially elevated melanoma risk — Caucasians with red hair have close to triple the melanoma risk of other Caucasians, independent of skin tone alone. This makes MC1R one of the more medically actionable trait genes: knowing your status is a legitimate reason for more vigilant sun protection and more frequent skin checks, regardless of what the anesthesia research eventually settles on.
What to Actually Do With This Information
- Mention it before a procedure. If you or a family member has red hair, or has a documented MC1R variant, it's worth mentioning to an anesthesiologist or dentist beforehand — not as a guarantee of a different dose, but as one more data point in a personalized plan.
- Prioritize sun protection and skin checks. This is the part of the MC1R story with the least scientific ambiguity, and the most direct, actionable payoff.
- Consider it alongside broader pharmacogenomic testing. MC1R is one gene among many that shape individual drug response — it's most useful viewed as part of a fuller pharmacogenomic picture, not in isolation.
MC1R Is One Piece of a Much Bigger Pharmacogenomic Picture
Dante Labs' whole genome sequencing reads MC1R along with the broader panel of genes that shape drug metabolism, pain response, and skin cancer risk.
Explore Whole Genome Sequencing →GENOME for 10% off